ArticleFrontiers in oncology2025

MiR-4664-3p as a potential diagnostic, prognostic, and immunotherapeutic biomarker in NSCLC: modulation of tumor progression through CD8 + T cell regulation.

Chun Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.